Conviviality Plc (LON:CVR), the UK’s leading independent wholesaler and distributor of alcohol and impulse, serving consumers through its franchised retail outlets and through hospitality and food service, announces that, after three successful years with the Company, Andrew Humphreys, Group CFO, will be leaving the business. Andrew leaves with our utmost appreciation and thanks for the significant role he has played in the transformation of the Company from its roots as the UK’s leading off-licence brand and alcohol wholesaler to Franchisees, to the UK’s leading independent wholesaler and distributor to the on-trade and off-trade. Andrew will step down from the Board on 30 October 2017 and will leave the business after a period of handover to his successor.
Conviviality is pleased to announce that Mark Moran will be joining the board of Conviviality Plc as Group CFO, effective from 30th October 2017. Mark has had over 20 years’ experience at CFO level across a number of different businesses. Mark has been CFO of three public companies – Porvair Plc, SSL International Plc and Premier Foods Plc – and latterly was CFO of the private equity owned Priory Healthcare Group before its acquisition by Acadia Healthcare in 2016. Mark comes with a proven track record of financial stewardship and has been involved with many acquisitions and disposals, business restructurings and major refinancing. We look forward to Mark joining the team.
Diana Hunter, CEO of Conviviality Plc, said: “We are hugely grateful for Andrew’s contribution to Conviviality, having played a key role in the Company’s significant growth, including his pivotal roles in the Matthew Clark and Bibendum PLB acquisitions. He leaves with the best wishes of the Board for his future career. We are delighted to welcome Mark to the Company and look forward to him supporting and contributing to the Company’s further development as the UK’s leading independent wholesaler and distributor of alcohol and impulse. “
Mark Moran, aged 57, holds or has held in the last 5 years the directorships set out in the appendix to this announcement. Other than as set out in the appendix, there is no further information on Mark Moran required to be disclosed under Rule 17 and Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.
